The Centers for Disease Control and Prevention (CDC) has updated its influenza statistics for the 2012-2013 influenza season for Week 1 ending Jan. 5, 2013. Public health officials are reporting that from Dec. 30, 2012 through Jan. 5, 2013, influenza activity remained elevated in the U.S., but may be decreasing in some areas.
The Centers for Disease Control and Prevention (CDC) has updated its influenza statistics for the 2012-2013 influenza season for Week 1 ending Jan. 5, 2013. Public health officials are reporting that from Dec. 30, 2012 through Jan. 5, 2013, influenza activity remained elevated in the U.S., but may be decreasing in some areas. Here are the details:
-Viral Surveillance: Of 12,876 specimens tested and reported by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories, 4,222 (32.8 percent) were positive for influenza.
- Pneumonia and Influenza Mortality: The proportion of deaths attributed to pneumonia and influenza (P&I) was slightly above the epidemic threshold.
- Influenza-Associated Pediatric Deaths: Two influenza-associated pediatric deaths were reported. One was associated with an influenza A (H3) virus and one was associated with an influenza A virus for which the subtype was not determined.
- Outpatient Illness Surveillance: The proportion of outpatient visits for influenza-like illness (ILI) was 4.3 percent; above the national baseline of 2.2 percent. Nine of 10 regions reported ILI above region-specific baseline levels. Twenty-four states and New York City experienced high ILI activity; 16 states experienced moderate ILI activity; five states experienced low ILI activity; five states experienced minimal ILI activity, and the District of Columbia had insufficient data.
- Geographic Spread of Influenza: Forty-seven states reported widespread geographic influenza activity; two states reported regional activity; the District of Columbia reported local activity; one state reported sporadic activity; Guam reported no influenza activity, and Puerto Rico and the U.S. Virgin Islands did not report.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.